Company Filing History:
Years Active: 2018
Title: Veronique Durieu: Innovator in Benzimidazole Derivatives
Introduction
Veronique Durieu is a notable inventor based in Brussels, Belgium. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on benzimidazole derivatives. Her research focuses on developing compounds that can modulate TNF activity, which is crucial in treating various human ailments.
Latest Patents
Veronique holds a patent for "Fused tricyclic benzimidazoles derivatives as modulators of TNF activity." This patent encompasses a series of tricyclic benzimidazole derivatives, including dihydro-1H-imidazo [1,2-a]benzimidazole, dihydro-1H-pyrrolo [1,2-a]benzimidazole, dihydro-1H-pyrazino[1,2-a]benzimidazole, dihydro-1H-[1,4]oxazino[4,3-a]benzimidazole, and dihydrothiazolo[3,4-a]benzimidazolem. These compounds are recognized for their potential benefits in treating and preventing various conditions, such as autoimmune and inflammatory disorders, neurological and neurodegenerative disorders, pain and nociceptive disorders, cardiovascular disorders, metabolic disorders, ocular disorders, and oncological disorders. Veronique has 1 patent to her name.
Career Highlights
Veronique Durieu is currently associated with UCB Biopharma Sprl, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding of TNF modulation and its implications for human health.
Collaborations
Throughout her career, Veronique has collaborated with esteemed colleagues, including Rikki Peter Alexander and Mark Daniel Calmiano. These partnerships have enhanced her research and contributed to the success of her projects.
Conclusion
Veronique Durieu is a pioneering inventor whose work on benzimidazole derivatives has the potential to impact the treatment of various serious health conditions. Her contributions to the field of pharmaceuticals are commendable and highlight the importance of innovation in medical research.